Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)
33.09
+0.73 (2.26%)
Jul 14, 2025, 2:45 PM CST
SHA:688639 Revenue
Anhui Huaheng Biotechnology had revenue of 687.06M CNY in the quarter ending March 31, 2025, with 37.20% growth. This brings the company's revenue in the last twelve months to 2.36B, up 15.96% year-over-year. In the year 2024, Anhui Huaheng Biotechnology had annual revenue of 2.18B with 12.37% growth.
Revenue (ttm)
2.36B
Revenue Growth
+15.96%
P/S Ratio
3.41
Revenue / Employee
1.08M
Employees
2,191
Market Cap
8.07B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.18B | 239.67M | 12.37% |
Dec 31, 2023 | 1.94B | 519.62M | 36.63% |
Dec 31, 2022 | 1.42B | 464.56M | 48.69% |
Dec 31, 2021 | 954.10M | 466.85M | 95.81% |
Dec 31, 2020 | 487.24M | -4.07M | -0.83% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |